Starpharma Pooled Development (SPL) News
Follow Starpharma Pooled Development (SPL) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Starpharma Raises Petalion Stake to 66%, Securing Majority Ownership
MNA | Oct 20, 2026, 01:02 AM UTC
M
Starpharma Seeks Trading Halt
EQUITY | Oct 15, 2026, 10:30 PM UTC
L
Edison Issues Report on Starpharma (SPL)
London, United Kingdom--(. - September 30, 2026) - Edison issues report on Starpharma ASX:SPLStarpharma is a biotechnology company specialised in targeted oncology, underpinned by its proprietary, clinically established
NEWS | Sep 30, 2026, 08:28 AM UTC